New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation MARLBOROUGH, Mass., Oct. 18, 2024 /PRNewswire/ -- ...

Boston Scientific Corp. recently received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview mapping software to be used with its Farapulse pulsed field ablation (PFA) ...

MARIETTA — Memorial Health System’s Department of Cardiology has announced the successful launch of the FARAPULSE Pulsed Field Ablation procedure. On May 8, Cardiac Electrophysiologist Dr. Maninder ...

MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of the ...

- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /CNW/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") today announced that it ...

MENLO PARK, CA, May 8, 2019 /CNW/ - FARAPULSE Inc. ("FARAPULSE" or "the "Company") today announced it has received Breakthrough Device designation from the Center for Devices and Radiological Health ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...

The FARAPULSE PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., intermittent) atrial fibrillation (AF) and is ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...